Unexpected Interruptions in the Inhaled Epoprostenol Delivery System: Incidence of Adverse Sequelae and Therapeutic Consequences in Critically Ill Patients.

Block, Jason M; Madhok, Jai; Owyang, Clark G; Merriman, Kristen R; Ruoss, Stephen J; Rao, Vidya K

Block, Jason M; Madhok, Jai; Owyang, Clark G; Merriman, Kristen R; Ruoss, Stephen J; Rao, Vidya K.

Afiliação

Block JM; Department of Anesthesiology, Pain, and Perioperative Medicine, Division of Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Madhok J; Department of Anesthesiology, Pain, and Perioperative Medicine, Divisions of Critical Care Medicine and Adult Cardiothoracic Anesthesiology, Stanford University School of Medicine, Stanford, CA.
Owyang CG; Department of Medicine, Division of Pulmonary and Critical Care Medicine, New York-Presbyterian/Weill Cornell Medical Center, New York, NY.
Merriman KR; Department of Respiratory Care Services, Stanford Healthcare, Palo Alto, CA.
Ruoss SJ; Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA.
Rao VK; Department of Anesthesiology, Pain, and Perioperative Medicine, Divisions of Critical Care Medicine and Adult Cardiothoracic Anesthesiology, Stanford University School of Medicine, Stanford, CA.

Crit Care Explor ; 3(10): e0548, 2021 Oct.

Article em En | MEDLINE | ID: mdl-34671745

Palavras-chave

aerogen; inhaled epoprostenol; medical device safety; nitric oxide; vibrating mesh nebulizer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google